Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters

Brain Research

Volumn 1280, Issue , 2009, Pages 195-200

  Bareggi, Silvio R ^a   Braida, Daniela ^b   Pollera, Claudia ^c   Bondiolotti, Gianpietro ^a   Formentin, Elena ^c   Puricelli, Maria ^c   Poli, Giorgio ^c   Ponti, Wilma ^c   Sala, Mariaelvina ^b  

^a Institute of Psychology   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Center of Excellence on Neurodegenerative Diseases   (Italy)

Author keywords

Biogenic amine; Memory; Oxidative stress; Scrapie infection

Indexed keywords

BIOGENIC AMINE; CLIOQUINOL; LIPID; NEUROTRANSMITTER; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FUNCTIONAL DISEASE; HISTOCHEMISTRY; HISTOPATHOLOGY; LIPID PEROXIDATION; LOCOMOTION; MEMORY; MEMORY DISORDER; MOTOR PERFORMANCE; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SCRAPIE; SYNAPSE; SYRIAN HAMSTER; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; BIOGENIC AMINES; BRAIN; CHELATING AGENTS; CLIOQUINOL; CRICETINAE; FEMALE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MEMORY; MEMORY DISORDERS; MESOCRICETUS; MOTOR ACTIVITY; RANDOM ALLOCATION; SCRAPIE; TIME FACTORS;

MESOCRICETUS AURATUS;

EID: 67649439146     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.031     Document Type: Article

References (21)

1. Ader R., Weijnen J.A.W.M., and Moleman P. Retention of a passive avoidance response as a function of the intensity and the duration of electric shock. Psychol. Sci. 26 (1972) 125-128
2. Bareggi S.R., Braida D., Gervasoni M., Carcassola G., Pollera C., Verzoni C., and Sala M. Neurochemical and behavioural modifications induced by scrapie infection in golden hamsters. Brain Res. 984 (2003) 237-241
3. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev., Drug Discov. 3 (2004) 205-214
4. Bondiolotti G., Sala M., Pollera C., Gervasoni M., Puricelli M., Ponti W., and Bareggi S.R. Pharmacokinetics and distribution of clioquinol in golden hamsters. J. Pharm. Pharmacol. 59 (2007) 387-393
5. Braida D., Pozzi M., Cavallini R., and Sala M. 3,4 Methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats. Behav. Neurosci. 116 (2002) 298-304
6. Brazier M.W., Lewis V., Ciccotosto G.D., Klug G.M., Lawson V.A., Cappai R., Ironside J.W., Masters C.L., Hill A.F., White A.R., and Collins S. Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease. Brain Res. Bull. 68 (2006) 346-354
7. Brown D.R. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol. 43 (2005) 229-243
8. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
9. Bush A.I. Metals and neuroscience. Curr. Opin. Chem. Biol. 4 (2000) 184-191
10. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., Huang X., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., and Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30 (2001) 665-676
11. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., and Bush A.I. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275 (2000) 19439-19442
12. Formentin E., Puricelli M., Pollera C., and Ponti W. Evaluation of clioquinol activity towards transmissible spongiform encephalopathies (TSE) in cellular models and cell-free systems. Vet. Res. Commun. 30 (2006) 253-255
13. Kimberlin R.H., and Walker C.A. Pathogenesis of scrapie (strain 263 K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67 (1986) 255-263
14. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30 (1995) 165-168
15. Lampert P.W., Gajdusek P.W., and Gibbs C.J.J.r. Subacute spongiform virus encephalopathies. Scrapie, Kuru and Creutzfeldt-Jakob disease: a review. Am. J. Pathol. 68 (1972) 626-652
16. Lee J.Y., Cole T.B., Palmiter R.D., Suh S.W., and Koh J.Y. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. 99 (2002) 7705-7710
17. Pollera C., Lucchini B., Formentin E., Bareggi S.R., Poli G., and Ponti W. Evaluation of anti-prionic activity of clioquinol in an in vivo model. Vet. Res. Comm. 29 Suppl. 2 (2005) 253-255
18. Prusiner S.B. Genetic and infectious prion diseases. Arch. Neurol. 50 (1993) 1129-1153
19. Sayre L.M., Perry G., Harris P.L.R., Liu Y., Schubert K.A., and Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74 (2000) 270-279
20. Terry R.D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55 (1996) 1023-1025
21. Yamamura H.I., and Snyder S.H. Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. 71 (1974) 1725-1729